Որոնման արդյունքները - Peter X. Adams
- Ցուցադրվում են 1 - 4 արդյունքները 4
-
1
-
2
Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: Combined results from the PRIMO-CABG I and II trials Peter K. Smith, Stanton K. Shernan, John C. Chen, Michel Carrier, Edward D. Verrier, Peter X. Adams, Thomas G. Todaro, Lawrence H. Muhlbaier, Jerrold H. Levy
Հրապարակվել է 2010Artigo -
3
Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention Paul W. Armstrong, Christopher B. Granger, Peter X. Adams, Christian W. Hamm, David R. Holmes, William W. O’Neill, Thomas G. Todaro, Alec Vahanian, Frans Van de Werf
Հրապարակվել է 2007Artigo -
4
ST-Segment Recovery and Outcome After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Christopher E. Buller, Yuling Fu, Kenneth W. Mahaffey, Thomas G. Todaro, Peter X. Adams, Cynthia M. Westerhout, Harvey D. White, Arnoud W.J. van ‘t Hof, Frans Van de Werf, Galen S. Wagner, Christopher B. Granger, Paul W. Armstrong
Հրապարակվել է 2008Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Internal medicine
Medicine
Cardiology
Myocardial infarction
Alternative medicine
Clinical endpoint
Confidence interval
Conventional PCI
Heart failure
Pathology
Percutaneous coronary intervention
Placebo
Randomized controlled trial
Anesthesia
Angioplasty
Blood pressure
Blood volume
Bolus (digestion)
Cardiac output
Cardiogenic shock
Cohort
Hazard ratio
Heart rate
Hemodynamics
Hypovolemia
Incidence (geometry)
Midazolam
Optics
Perioperative
Pharmacodynamics